Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 21;53(4):353-360.
doi: 10.14744/SEMB.2019.25991. eCollection 2019.

Radiotherapy in Lung Cancer: Current and Future Role

Esengül Koçak Uzel  1 , Metin Figen  1 , Ömer Uzel  2
Affiliations
Review

Radiotherapy in Lung Cancer: Current and Future Role

Esengül Koçak Uzel et al. Sisli Etfal Hastan Tip Bul. .

Abstract

Lung cancer is divided into two subgroups concerning its natural course and treatment strategies as follows: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). In this review, for NSCLC, the role of stereotactic body radiation therapy (SBRT) in early-stage, chemoradiation in the locally advanced stage, post-operative radiotherapy for patients with high risk after surgery and radiotherapy for metastatic disease will be discussed. Also, for SCLC, the role and timing of thoracic irradiation and prophylactic cranial irradiation (PCI) for the limited and extensive stages will be discussed.

Keywords: Lung Cancer; Non-small cell lung cancer (NSCLC); Small cell lung cancer (SCLC); prophylactic cranial irradiation (PCI); stereotactic body radiation therapy (SBRT).

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

References

    1. Ihde DC. Chemotherapy of lung cancer. N Engl J Med. 1992;327:1434–41. - PubMed
    1. Uzel EK, Abacıoğlu U. Treatment of early stage non-small cell lung cancer:surgery or stereotactic ablative radiotherapy? Balkan Med J. 2015;32:8–16. - PMC - PubMed
    1. Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer:updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2:S94–100. - PubMed
    1. Grills IS, Hope AJ, Guckenberger M, Kestin LL, Werner-Wasik M, Yan D, et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol. 2012;7:1382–93. - PubMed
    1. Liu F, Tai A, Lee P, Biswas T, Ding GX, El Naqa I, et al. Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models. Radiother Oncol. 2017;122:286–94. - PMC - PubMed

LinkOut - more resources